These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30893577)

  • 21. Calcium/Calmodulin-Dependent Protein Kinase II Delta Inhibition and Ventricular Remodeling After Myocardial Infarction: A Randomized Clinical Trial.
    Boyle AJ; Schultz C; Selvanayagam JB; Moir S; Kovacs R; Dib N; Zlotnick D; Al-Omary M; Sugito S; Selvarajah A; Collins N; McLachlan G
    JAMA Cardiol; 2021 Jul; 6(7):762-768. PubMed ID: 33851966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of postprocedural anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A post-hoc analysis of the randomized INNOVATION trial.
    Song PS; Kim MJ; Jeon KH; Lim S; Park JS; Choi RK; Kim JS; Lee HJ; Kim TH; Choi YJ; Lim DS; Yu CW
    Medicine (Baltimore); 2019 Apr; 98(17):e15277. PubMed ID: 31027084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights.
    Haig C; Carrick D; Carberry J; Mangion K; Maznyczka A; Wetherall K; McEntegart M; Petrie MC; Eteiba H; Lindsay M; Hood S; Watkins S; Davie A; Mahrous A; Mordi I; Ahmed N; Teng Yue May V; Ford I; Radjenovic A; Welsh P; Sattar N; Oldroyd KG; Berry C
    JACC Cardiovasc Imaging; 2019 Jun; 12(6):993-1003. PubMed ID: 30031700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G-CSF for Extensive STEMI.
    Achilli F; Pontone G; Bassetti B; Squadroni L; Campodonico J; Corrada E; Facchini C; Mircoli L; Esposito G; Scarpa D; Pidello S; Righetti S; Di Gennaro F; Guglielmo M; Muscogiuri G; Baggiano A; Limido A; Lenatti L; Di Tano G; Malafronte C; Soffici F; Ceseri M; Maggiolini S; Colombo GI; Pompilio G;
    Circ Res; 2019 Jul; 125(3):295-306. PubMed ID: 31138020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol - The COVERT-MI Study.
    Bresson D; Roubille F; Prieur C; Biere L; Ivanes F; Bouleti C; Dubreuil O; Rioufol G; Boutitie F; Sideris G; Elbaz M; Bochaton T; De Bourguignon C; El Jonhy N; Dufay N; Dhelens C; Croisille P; Prunier F; Angoulvant D; Ovize M; Maucort-Boulch D; Mewton N
    Cardiology; 2021; 146(2):151-160. PubMed ID: 33582664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of early cardiac magnetic resonance imaging functional and geometric indexes for adverse left ventricular remodelling in patients with anterior ST-segment elevation myocardial infarction: A report from the CIRCUS study.
    Pezel T; Besseyre des Horts T; Schaaf M; Croisille P; Bière L; Garcia-Dorado D; Jossan C; Roubille F; Cung TT; Prunier F; Meyer E; Amaz C; Derumeaux G; de Poli F; Hovasse T; Gilard M; Bergerot C; Thibault H; Ovize M; Mewton N
    Arch Cardiovasc Dis; 2020 Nov; 113(11):710-720. PubMed ID: 33160891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.
    Najjar SS; Rao SV; Melloni C; Raman SV; Povsic TJ; Melton L; Barsness GW; Prather K; Heitner JF; Kilaru R; Gruberg L; Hasselblad V; Greenbaum AB; Patel M; Kim RJ; Talan M; Ferrucci L; Longo DL; Lakatta EG; Harrington RA;
    JAMA; 2011 May; 305(18):1863-72. PubMed ID: 21558517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.
    Hayashi M; Tsutamoto T; Wada A; Tsutsui T; Ishii C; Ohno K; Fujii M; Taniguchi A; Hamatani T; Nozato Y; Kataoka K; Morigami N; Ohnishi M; Kinoshita M; Horie M
    Circulation; 2003 May; 107(20):2559-65. PubMed ID: 12732605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.
    Roolvink V; Ibáñez B; Ottervanger JP; Pizarro G; van Royen N; Mateos A; Dambrink JE; Escalera N; Lipsic E; Albarran A; Fernández-Ortiz A; Fernández-Avilés F; Goicolea J; Botas J; Remkes W; Hernandez-Jaras V; Kedhi E; Zamorano JL; Navarro F; Alfonso F; García-Lledó A; Alonso J; van Leeuwen M; Nijveldt R; Postma S; Kolkman E; Gosselink M; de Smet B; Rasoul S; Piek JJ; Fuster V; van 't Hof AWJ;
    J Am Coll Cardiol; 2016 Jun; 67(23):2705-2715. PubMed ID: 27050189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial.
    Le Corvoisier P; Gallet R; Lesault PF; Audureau E; Paul M; Ternacle J; Ghostine S; Champagne S; Arrouasse R; Bitari D; Mouillet G; Dubois-Randé JL; Berdeaux A; Ghaleh B; Deux JF; Teiger E
    BMC Cardiovasc Disord; 2018 Oct; 18(1):193. PubMed ID: 30340532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of comprehensive remote ischemic conditioning in anterior ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Design and rationale of the CORIC-MI randomized trial.
    Song L; Yan H; Zhou P; Zhao H; Liu C; Sheng Z; Tan Y; Yi C; Li J; Zhou J
    Clin Cardiol; 2018 Aug; 41(8):997-1003. PubMed ID: 29726013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function.
    García-Ruiz JM; Fernández-Jiménez R; García-Alvarez A; Pizarro G; Galán-Arriola C; Fernández-Friera L; Mateos A; Nuno-Ayala M; Aguero J; Sánchez-González J; García-Prieto J; López-Melgar B; Martínez-Tenorio P; López-Martín GJ; Macías A; Pérez-Asenjo B; Cabrera JA; Fernández-Ortiz A; Fuster V; Ibáñez B
    J Am Coll Cardiol; 2016 May; 67(18):2093-2104. PubMed ID: 27052688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-Dependent Myocardial Necrosis in Patients With ST-Segment-Elevation Myocardial Infarction Without Angiographic Collateral Flow Visualized by Cardiac Magnetic Resonance Imaging: Results From the Multicenter STEMI-SCAR Project.
    Greulich S; Mayr A; Gloekler S; Seitz A; Birkmeier S; Schäufele T; Bekeredjian R; Zuern CS; Seizer P; Geisler T; Müller KAL; Krumm P; Nikolaou K; Klug G; Reinstadler S; Pamminger M; Reindl M; Wahl A; Traupe T; Seiler C; Metzler B; Gawaz M; Windecker S; Mahrholdt H
    J Am Heart Assoc; 2019 Jun; 8(12):e012429. PubMed ID: 31181983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction-Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trial.
    Duengen HD; Kim RJ; Zahger D; Orvin K; Kornowski R; Admon D; Kettner J; Shimony A; Otto C; Becka M; Kanefendt F; Romo AI; Hasin T; Ostadal P; Rojas GC; Senni M;
    Am Heart J; 2020 Jun; 224():129-137. PubMed ID: 32375104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials.
    Stienen S; Rossignol P; Barros A; Girerd N; Pitt B; Zannad F; Ferreira JP
    Clin Res Cardiol; 2020 Feb; 109(2):194-204. PubMed ID: 31250134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of Left Ventricular Remodeling After Myocardial Infarction in Patients With a Patent Infarct Related Coronary Artery After Percutaneous Coronary Intervention (from the Post-Myocardial Infarction Remodeling Prevention Therapy [PRomPT] Trial).
    Garber L; McAndrew TC; Chung ES; Stancak B; Svendsen JH; Monteiro J; Fischer TM; Kueffer F; Ryan T; Bax J; Leon AR; Stone GW
    Am J Cardiol; 2018 Jun; 121(11):1293-1298. PubMed ID: 29580631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac magnetic resonance-tissue tracking for the early prediction of adverse left ventricular remodeling after ST-segment elevation myocardial infarction.
    Cha MJ; Lee JH; Jung HN; Kim Y; Choe YH; Kim SM
    Int J Cardiovasc Imaging; 2019 Nov; 35(11):2095-2102. PubMed ID: 31267265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effects of Hydrogen Gas Inhalation on Adverse Left Ventricular Remodeling After Percutaneous Coronary Intervention for ST-Elevated Myocardial Infarction　- First Pilot Study in Humans.
    Katsumata Y; Sano F; Abe T; Tamura T; Fujisawa T; Shiraishi Y; Kohsaka S; Ueda I; Homma K; Suzuki M; Okuda S; Maekawa Y; Kobayashi E; Hori S; Sasaki J; Fukuda K; Sano M
    Circ J; 2017 Jun; 81(7):940-947. PubMed ID: 28321000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI).
    Caplice NM; DeVoe MC; Choi J; Dahly D; Murphy T; Spitzer E; Van Geuns R; Maher MM; Tuite D; Kerins DM; Ali MT; Kalyar I; Fahy EF; Khider W; Kelly P; Kearney PP; Curtin RJ; O'Shea C; Vaughan CJ; Eustace JA; McFadden EP
    Am Heart J; 2018 Jun; 200():110-117. PubMed ID: 29898838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.